TSN — Tyson Foods, Inc.
Tyson Foods, Inc. operates as a prominent global food producer, encompassing a broad range of activities across four core divisions: Beef, Pork, Chicken, and Prepared Foods. Within its Beef and Pork segments, the company manages the entire process from live cattle and hogs to their transformation into various meat products.
Price chart & technical analysis
Loading chart…
As of 2026-09-13, TSN trades at $52.98 near its 52-week low of $50.56 after a Sept. 3 FY2026 guidance cut driven by beef losses; trailing P/E is 31.7x on $1.67 EPS, but forward P/E is ~14.4x on next-FY EPS of $3.69.
The market is bearish: TSN is down 12.17% over six months and 5.07% over one month as of 2026-09-13, sitting just above its 52-week low of $50.56. The Sept. 3 guidance cut widened expected FY2026 beef operating losses to $(775)-$(625)M and reduced total adjusted operating income guidance to $1.85-$2.05B, while Sept. 10 securities-litigation investigations added disclosure risk. Analysts cut targets (Piper Sandler $78 to $66; Goldman $77 to $67) though most kept Buy/Overweight ratings, and insider buying near $51.50 signals some contrarian interest.
Revenue has been range-bound, not declining: quarterly revenue has held roughly $13.0B-$14.3B from late 2023 through Q3 FY2026. The trend is margin compression, not revenue deterioration. TTM operating margin is only 2.5%, net margin 1.0%, and ROIC 3.0%, with gross margin 6.2%. Earnings bottomed in FY2025: quarterly EPS was $0.02, $0.18, $0.13, and $0.25 across the four quarters ending Sept. 2025, then improved to $0.73 (Mar. 2026) and $0.52 (Jun. 2026). But Q1 FY2026 operating income fell to $431M from $580M a year earlier, and the Sept. 2026 guidance cut shows beef losses are worsening; chicken is the relative bright spot. This looks like a cyclical beef trough rather than a structural revenue decline, but recovery timing is uncertain.
Fair, with a cyclical-cheap tilt only if forward estimates hold. As of 2026-09-13, price $52.98 gives trailing P/E 31.7x on $1.67 EPS, PEG -1.22 (meaningless with negative growth), P/B 1.01x, P/S 0.34x versus 5-year average P/S 0.43x, and dividend yield 3.71%. Forward P/E is ~14.4x on next-FY EPS of $3.688, well below the 5-year average P/E of 20.5x. The deterministic valuation context is Neutral vs. its own history. So trailing valuation looks expensive, forward valuation looks fair-to-cheap, but the forward number depends on a beef recovery that has not yet appeared.
The stock is not pricing in a full recovery: at $52.98, it trades at ~14.4x next-FY EPS of $3.688, while the 5-year average P/E is 20.5x. If Tyson merely earns the forward estimate and trades at 14-16x, fair value is roughly $52-$59. The market is pricing a modest earnings inflection, not a return to peak margins. The risk is that FY2027 estimates are too high; if beef losses persist and EPS stays near $2, the stock would still look expensive. Conversely, any evidence of cattle-cycle relief or beef restructuring savings could drive multiple expansion toward the mid-$60s analyst targets.
As of 2026-09-13, TSN is in a downtrend: RSI(14) is 38.04, price is 4.64% below its 20-day SMA, 7.27% below its 50-day SMA, and 12.37% below its 200-day SMA. It is near the bottom of its 52-week range ($50.56-$69.48). The one-week return is +3.03%, a small bounce, but the one-month (-5.07%), three-month (-7.75%), and six-month (-12.17%) returns remain negative. Technically this is weak and not yet oversold enough to signal a durable entry; waiting for a close above the 20-day SMA or a higher low would reduce timing risk.
- U.S. cattle cycle: the tightest cattle inventory in decades has driven livestock costs sharply higher, crushing beef processing spreads for Tyson and the entire packer complex.
- Consumer budget fatigue: cautious discretionary food spending, especially in foodservice, pressures higher-margin prepared-food and value-added protein demand.
- Regulatory risk: proposed Country of Origin Labeling for imported beef and broader political scrutiny of meat-packer margins could add compliance costs and margin oversight.
- Debt and rates: Tyson issued $1B in senior notes on Aug. 10, 2026, and carries $6.58B of long-term debt; refinancing costs and interest expense matter with D/E at 0.443.
- Protein-market divergence: chicken and pork are profitable while beef is deeply loss-making, so segment mix and feed/input costs drive earnings volatility.
- Q4/FY2026 earnings release in early-to-mid Nov. 2026: final beef loss magnitude and initial FY2027 guidance are the next major reset.
- Execution of beef restructuring: consolidation to three central U.S. facilities and progress on structural cost cuts entering FY2027.
- Legal/regulatory updates: securities class-action investigations related to the Aug. 10 debt offering and Sept. 3 guidance cut, plus any COOL or meat-packing margin regulation.
- Insider buying: CEO-elect Jeffrey Schomburger's recent purchases near $51.50 may signal internal confidence.
- Chicken segment momentum: continued value-added mix and retail partnerships could offset beef weakness.
- Beef losses worsen or persist longer than guided: the FY2026 beef operating loss is expected at $(775)-$(625)M, and the cattle cycle could keep spreads compressed for multiple years.
- Forward EPS estimates prove too optimistic: next-FY EPS of $3.688 versus TTM $1.672 implies a large recovery that may not materialize.
- Securities litigation and disclosure risk around the $1B Aug. 10 debt offering and the Sept. 3 guidance cut could create legal costs and management distraction.
- Dividend payout exceeds trailing EPS: the 3.71% yield looks attractive, but the annual dividend is above TTM EPS and depends on FCF staying above ~$1.1B.
- Execution risk in beef restructuring and potential consumer/foodservice demand weakness.
Not an attractive investment right now. The trailing fundamentals are genuinely weak—2.5% operating margin, 1.0% net margin, 3.0% ROIC—and the Sept. 3 guidance cut plus litigation risk make the near-term path uncertain. There is a value case if you believe beef is at a cyclical trough and chicken earnings hold, but with the stock below all key moving averages and forward estimates still requiring a big recovery, the risk/reward favors waiting for evidence of stabilization rather than buying the dip.
Applied a 15.5x P/E to next-FY consensus EPS of $3.688, a discount to the 5-year average P/E of 20.5x to account for the cyclical beef trough, the Sept. 3 guidance cut, and litigation risk. Cross-checked with 8.5x forward EV/EBITDA on ~$3.05B EBITDA (midpoint FY2026 adjusted operating income plus ~$1.1B D&A), which yields a similar ~$56.7 equity value per share.
The deterministic score of 41.7 (Weak Fundamentals) is directionally fair on trailing data: Tyson's TTM operating margin is 2.5%, ROIC is 3.0%, net margin is 1.0%, and the Sept. 3 guidance cut confirms real near-term deterioration. But the formula is entirely backward-looking and cannot distinguish a cyclical beef trough from structural decline. Chicken is profitable ($1.85-$1.95B expected operating income), the balance sheet is reasonable (D/E 0.443, current ratio 1.433), and the stock trades at 1.0x book with a 6.2% TTM FCF yield. I would nudge the score into the low-50s / Fair Fundamentals to reflect forward normalization potential, but I would not move it much higher because cattle-cycle timing and litigation risk are real. Hence Partially Agree, not Agree or Disagree.
AI-generated analysis for informational purposes only, not financial advice.